Martiadis V
Department of Mental Health, ASL Napoli 1 Centro, Community Mental Health Center DS 25, Naples, 80125, Italy. vassilis.martiadis@gmail.com.
PreprintKetamine
Intranasal Esketamine for Treatment-Resistant Depression: A Practical Clinical Guide to Patient Selection, Dosing, Combination Strategies and Adverse-Event Management
ArticleKetamine
Ketamine and esketamine during breastfeeding: a systematic review of human pharmacokinetic, infant and lactation outcomes.
ArticleKetamine
Reduction of Suicidality and Depressive Symptoms with Esketamine: Focus on Gender Differences
ArticleKetamine
Glutamatergic Resonance and Dopaminergic Stability: Intranasal Esketamine in Treatment-Resistant Depression with Comorbid ADHD and Autism Spectrum Disorder – A Case Report
ArticleKetamine
Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopathological Reflections
ArticleKetamine
Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression
ArticleKetamine
Dissociation Does Not Mediate Antidepressant Response to Esketamine: A Real-World Longitudinal Study with 6-Month Follow-Up
ArticleKetamine
Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.
ArticleKetamine
Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder.
ArticleKetamine
Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report.
ArticlePsilocybin
From trial to clinic: psilocybin's efficacy in routine treatment-resistant depression.
ArticleKetamine
Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study.
ArticleKetamine
Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal.
ArticleKetamine
Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A real-world longitudinal study of suicidal ideation and self-harm.
ArticleKetamine
Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports.
ArticleKetamine
Integrating Psychiatric, Psychotherapeutic, and Nursing Care in Intranasal Esketamine for Treatment-Resistant Depression.
ArticleKetamine
Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study.
ArticleKetamine
Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality.
PreprintKetamine
Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports
ArticleKetamine
Gender Differences in Suicidal and Self-Harming Responses to Esketamine: A Real-World Retrospective Study.
ArticleKetamine
Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study.
ArticleKetamine
Esketamine-induced dissociation: just a side effects or a potential antidepressant effect booster?
ArticleKetamine
Metacogntive training add-on to esketamine treatment in TRD patients: effects on depressive rumination
ArticleKetamine
Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.
ArticleKetamine
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).
ArticleKetamine
Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group.
ArticleKetamine
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.
ArticleKetamine
Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies.
ArticleKetamine
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review.
ArticleKetamine
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).
ArticleKetamine